A molecule that never reaches the bloodstream has little therapeutic value, regardless of what its label promises. This challenge lies at the heart of the global nutraceutical industry, a market valued at over $450 billion and projected to grow at more than 7% annually. Pharmaceutical, consumer health, and life sciences...
